Taro Pharmaceutical Industries Ltd, the Israeli subsidiary of Sun Pharmaceutical Industries Ltd, on Wednesday said its board has approved the repurchase of shares worth $250 million. The post Sun Pharma arm Taro plans share repurchase worth $250m appeared first on DealStreetAsia. Via:: Deal Street Asia
↧